Research Grants Received

Major Research Project

Name of Principal Investigator Duration of project Name of the research project Amount / Fund received Name of funding agency Department of recipient Year of Sanction
Dr. S. N. Mokale 03 years Development of some anti-inflammatory agents using modern drug design Tech. 13.49 lakh UGC Pharma Chemistry 2010
Dr. J. N. Sangshetti 03 years Synthesis and Antifungal Activity of Some New Quinoline Analogues 6.30 lakh UGC Quality Assurance 2011
Dr. A. G. Nikalje 03 years Synthesis and Anticonvulsant activity of some hybrid heterocycles 13.05 lakh UGC Pharma Chemistry 2011
Dr. J. N. Sangshetti 01 years Modernization of Pharmaceutical Chemistry Laboratory 13.80 lakh MODROBS/ AICTE Quality Assurance 2011
Dr. Zahid Zaheer 03 years Synthesis pharmacological screening of some new substituted-1,2,4- oxadiazoles as anti-inflammatory agents 12.08 lakh UGC Quality Assurance 2012
Dr. S. N. Mokale 03 years Development of Selective Estrogen Receptor Modulators for Treatment of Breast Cancer: Design, Synthesis, In-Vitro and In-Vivo Screening 25.22 lakh Fast Track Project for Young Scientist / DST Pharma Chemistry 2012
Dr. J. N. Sangshetti 03 years Design & synthesis of Novel Inhibitor of Peptide Deformylase as Antibacterial Agent 25.52 lakh Fast Track Project for Young Scientist / DST Quality Assurance 2013
Dr. H. D. Une 01 years Modernization of Pharmacology Laboratory 8.0 lakh MODROBS/ AICTE Pharmacology 2013
Dr. Rana Zainuddin 02 years Nanosponges- Novel Drug carrier for enhancement of solubility &stability of Drug 4.45 lakh UGC Quality Assurance 2014
Mr. Nikhil Sakale 02 years Chemomodulatory influence of medicinal herbs in chemically induced carcinoma 3.50 lakh UGC Pharmacology 2014
Dr.Santosh Mokale 03 years Design and Development of Hybrid Inhibitor to synchronously act on four biochemically distinct target for suppression of tumor growth in a synergistic manner 36.6 lakh SERB EMEQ Pharma Chemistry 2017
Dr. J. N. Sangshetti 03 years Design, Synthesis and Biological Evaluation of Some New Mur B, Mur C, Mur D,Mur E and Mur F Inhibitors as Antibacterial Agents 36.55 lakh SERB EMR Quality Assurance 2018
Dr.Santosh Mokale 03 years Targetting KRAS mutant with aCovalent G12C Specific Inhibitor: Design Synthesis and Anticancer Screening of KRASG12C inhibitor for KRAS Mutant Cancers. 48.23 lakh SERB EMEQ Pharma Chemistry 2022

Minor Research Project

Name of Principal Investigator Duration of project Name of the research project Amount / Fund received Name of funding agency Department of recipient Year of Sanction Year of Completion
Dr. Rana Zainuddin 01 year Cross-linked polymers for dissolution enhancement of BCS class II Drug. 25,000 Dr B A M University Quality Assurance 2018 2020

Industry Sponsored Projects

Date From-To Name of faculty (Chief Consultant) Client Organization Title of Consultancy of project Amount received (in Rupees)
25/08/2015 to 01/12/2015 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Ex- Vivo Comparative Permeation of Diclofenac Gels 62,000
08/08/2016 to 26/10/2016 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Comparative Permeation Studies of Luliconazole Creams 70,000
August-2016 Dr. S.R. Lahoti Gebbs Health Care Solutions Training Consultancy for Medical Coders 3,25,000
08/08/2016 to 26/10/2016 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Comparative Permeation Studies of Luliconazole Lotion Formulations 70,000
08/08/2016 to 26/10/2016 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Comparative Permeation Studies of Decapeptide Solution Formulations 70,000
07/03/2017 to 04/07/2017 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Comparative Permeation Studies of Clindamycin Lotion Formulations 70,000
07/03/2017 to 04/07/2017 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Comparative Permeation Studies of Clindamycin Gel Formulations 70,000
07/03/2017 to 04/07/2017 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Comparative Permeation Studies of Spironolactone Cream Formulations 40,000
11/05/2017 To 05/08/2017 Dr. S.R. Lahoti Gebbs Health Care Solutions Training Consultancy for Medical Coders 70,000
26/04/2018 to 08/06/2018 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Ex-vivo Comparative Permeation Study between Muscodac gel and Volini gel. 85,000
11/09/2018 to 04/01/2019 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Ex-vivo Comparative Permeation Studyof four Luliconazole Gel Formulations 1,70,000
21/8/2019 to 21/01/2020 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Ex- Vivo Comparative Permeation of Muscodac Gel Volini Gel 85,000
31/5/2019 to 30/08/2019 Dr. S.R. Lahoti Alkem Laboratories Ltd. Taloja, New Mumbai Ex- Vivo Permeation of Melbild lotion 65,000
24/4/2018 to 24/7/2018 Dr. Furquan Khan Lupin Limited Tablet Sugar Coating Trials 30,000
19/10/2019 to 18/01/2020 Dr. Furquan Khan Lupin Limited Tablet Sugar Coating Trials 30,000